BlackRock Institutional Trust’s Novartis NVS Stock Holding History

BlackRock Institutional Trust’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.89M	Buy	+28,980	New	+$1.88M	﹤0.01%	3071
2016 Q2	–	Sell	-3,571	Closed	-$232K	–	3931
2016 Q1	$232K	Buy	+3,571	New	+$243K	﹤0.01%	3602
2015 Q3	–	Sell	-54,787	Closed	-$4.83M	–	3970
2015 Q2	$4.83M	Buy	+54,787	New	+$5.03M	﹤0.01%	2778
2014 Q3	–	Sell	-1,076	Closed	-$87K	–	3909
2014 Q2	$87K	Buy	+1,076	New	+$84.6K	﹤0.01%	3771

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

BlackRock Institutional Trust's NVS Position: Q4 2016 in Review

BlackRock Institutional Trust opened a new position in Novartis (NVS) in Q4 2016: 28,980 shares worth $1.89M. The stake represents ﹤0.01% of the portfolio and ranks #3071 among its holdings. This is a return to the name: BlackRock Institutional Trust previously reported a position in NVS as recently as Q1 2016.

BlackRock Institutional Trust first reported a position in NVS in Q2 2014 and has held it in 4 quarters since. The position peaked at $4.83M in Q2 2015. 904 funds tracked by Wall St. Rank hold NVS as of Q4 2016.

BlackRock Institutional Trust held 28,980 shares of Novartis worth $1.89M as of Q4 2016.
Novartis was a new BlackRock Institutional Trust position in Q4 2016.
Novartis made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3071 holding.
BlackRock Institutional Trust first reported a position in Novartis in Q2 2014 and has held it in 4 quarters since.
BlackRock Institutional Trust's Novartis position peaked at $4.83M in Q2 2015.
904 funds tracked by Wall St. Rank held Novartis as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.